{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:03:33Z","timestamp":1768262613422,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neuroscience.2013.06.009","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T03:35:58Z","timestamp":1371267358000},"page":"299-306","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis"],"prefix":"10.1016","volume":"248","author":[{"given":"A.","family":"Aminian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Noorbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ghazi-Khansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kafami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.","family":"Mehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2013.06.009_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0197-4580(96)00162-5","article-title":"The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys","volume":"18","author":"Arnsten","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0091-3057(90)90385-U","article-title":"The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates","volume":"35","author":"Barnes","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s001090050101","article-title":"Role of macrophages\/microglia in multiple sclerosis and experimental allergic encephalomyelitis","volume":"75","author":"Benveniste","year":"1997","journal-title":"J Mol Med"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/135245859500100302","article-title":"Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis treatment","volume":"1","author":"Bolton","year":"1995","journal-title":"Mult Scler"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/357695a0","article-title":"Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation","volume":"357","author":"Clipstone","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","article-title":"Mouse models for multiple sclerosis: historical facts and future implications","volume":"1812","author":"Croxford","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0035","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/01.wnl.0000275228.13012.7b","article-title":"Pathogenesis of myelin\/oligodendrocyte damage in multiple sclerosis","volume":"68","author":"Dhib-Jalbut","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri1807","article-title":"Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells","volume":"6","author":"Dong","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-009-9188-9","article-title":"Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"El-Behi","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.028","article-title":"The neuronal 5-HT3 receptor network after 20years of research\u2014evolving concepts in management of pain and inflammation","volume":"560","author":"Faerber","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0960327110362702","article-title":"Granisetron ameliorates acetic acid-induced colitis in rats","volume":"29","author":"Fakhfouri","year":"2010","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.drudis.2012.02.009","article-title":"Impact of 5-HT3 receptor antagonists on peripheral and central diseases","volume":"17","author":"Fakhfouri","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/03009740410006998","article-title":"Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes","volume":"33","author":"Fiebich","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/03009740410006952","article-title":"Expression of 5-HT3A receptors in cells of the immune system","volume":"33","author":"Fiebich","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jnr.20165","article-title":"FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis","volume":"77","author":"Gold","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrn784","article-title":"New concepts in the immunopathogenesis of multiple sclerosis","volume":"3","author":"Hemmer","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02249414","article-title":"Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system","volume":"125","author":"Hodges","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0960-894X(00)00670-3","article-title":"The 5-HT3 antagonist tropisetron (ICS 205\u2013930) is a potent and selective alpha7 nicotinic receptor partial agonist","volume":"11","author":"Macor","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","article-title":"The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation","volume":"151","author":"Jonge","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2005.07.021","article-title":"Blockade of 5-HT (3) receptor with MDL 72222 and Y 25130 reduces beta-amyloid protein (25\u201335)-induced neurotoxicity in cultured rat cortical neurons","volume":"520","author":"Ju","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2012.10.015","article-title":"Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function","volume":"255","author":"Kafami","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(99)00101-0","article-title":"5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation","volume":"99","author":"Khan","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.20.081701.141316","article-title":"T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire","volume":"20","author":"Kuchroo","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2362.2009.02102.x","article-title":"Anti-inflammatory effects of 5-HT3 receptor antagonist, tropisetron on experimental colitis in rats","volume":"39","author":"Mousavizadeh","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0130","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2174\/156802606778522122","article-title":"New treatment options using 5-HT3 receptor antagonists in rheumatic diseases","volume":"6","author":"M\u00fcller","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-007-0403-9","article-title":"The classification of fibromyalgia syndrome","volume":"27","author":"M\u00fcller","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.20052148","article-title":"Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"203","author":"Noorbakhsh","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0733-8619(18)30061-6","article-title":"The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis","volume":"13","author":"Owens","year":"1995","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2011.03.053","article-title":"Tropisetron ameliorates ischemic brain injury in an embolic model of stroke","volume":"1392","author":"Rahimian","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jnnp.62.3.282","article-title":"Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor","volume":"62","author":"Rice","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1478-811X-7-25","article-title":"Novel inhibitors of the calcineurin\/NFATc hub-alternatives to CsA and FK506?","volume":"7","author":"Sieber","year":"2009","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0165","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/nprot.2006.285","article-title":"Active induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0170","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/eji.1830210620","article-title":"Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls","volume":"21","author":"Sun","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bcp.2005.04.031","article-title":"The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway","volume":"70","author":"Vega","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.06.009_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"Weiner","year":"2008","journal-title":"J Neurol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221300506X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221300506X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T14:38:06Z","timestamp":1563201486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221300506X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"alternative-id":["S030645221300506X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2013.06.009","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}